Kylonib 150mg (Nilotinib Capsule) 150mg

Kylonib 150mg capsules contain nilotinib, a kinase inhibitor prescribed for certain blood cancers. This oral treatment targets specific proteins to support disease management. Store at room temperature away from moisture. Always follow healthcare provider instructions.

Strength

150mg

Pack Size

28s

Storage

Ambient

Manufacturer / TM Owner

Beta Drugs Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Kylonib 150mg is used to treat chronic myeloid leukemia (CML) in adults and children. It works by blocking abnormal proteins that cause uncontrolled cell growth. Patients with Philadelphia chromosome-positive CML may benefit from this therapy. Always consult a doctor to confirm suitability.

Side Effects

Kylonib 150mg capsules are taken by mouth, usually once or twice daily. Some users report mild stomach discomfort or headaches after starting treatment. These effects often lessen as the body adjusts. Keep track of any persistent symptoms and discuss them with a healthcare professional.

Precautions & Warnings

Keep Kylonib 150mg capsules in their original packaging at room temperature. Avoid exposing them to heat or direct sunlight. Do not open or crush the capsules unless instructed by a doctor. Keep this medication out of reach of children and pets.

Avoid Interactions

Kylonib 150mg may interact with other medications, including certain antibiotics and antifungals. Avoid grapefruit products while taking this drug, as they can increase side effects. Discuss all current medications with a healthcare provider before starting nilotinib. Alcohol use should be limited.

References

Frequently Asked Questions

Kylonib 150mg is used to treat chronic myeloid leukemia (CML) in adults and children with Philadelphia chromosome-positive disease.

Store Kylonib 150mg capsules at room temperature in their original packaging, away from moisture and heat.

Kylonib 150mg can be taken with or without food, but it should be swallowed whole with water.

Some users may experience mild side effects like stomach discomfort or headaches, which should be reported to a doctor if persistent.

Nilotinib may harm an unborn baby. Discuss pregnancy plans or risks with a healthcare provider before using this medication.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.